SECsense Logo

Amicus Therapeutics, Inc. 8-K Report: Key Updates as of January 12, 2025

$FOLD
Form 8-K
Filed on: 2025-01-13
Source
Amicus Therapeutics, Inc. 8-K Report: Key Updates as of January 12, 2025

Here’s a summary of the key information extracted from the provided financial report section:

  1. Entity Information:
  • Name: Amicus Therapeutics, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001178879
  • IRS Employer Identification Number: 71-0869350
  • Address: 47 Hulfish Street, Princeton, NJ 08542
  • Phone Number: 609-662-2000
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 12, 2025
  • SEC File Number: 001-33497
  1. Common Stock Details:
  • Par Value: $0.01
  • Ticker Symbol: FOLD
  • Exchange: NASDAQ
  1. Financial Reporting Context:
  • Report Date: January 12, 2025 (as of date)
  • Currency: USD (US Dollars)
  • Measurement Units:
    • USD (for monetary values)
    • Shares (for stock quantities)
    • USD per Share (for pricing)

Insights:

  • The report indicates a specific event or financial update related to Amicus Therapeutics as filed on an 8-K, which is typically used to report major events that shareholders should know about.
  • The choice of a common stock with a low par value of $0.01 suggests a potential for higher share issuance flexibility.
  • The report is structured in compliance with XBRL (eXtensible Business Reporting Language), indicating a commitment to transparent and standardized financial reporting.

This information is crucial for stakeholders looking to understand the company’s operational status and recent developments as of the specified filing date.